ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1,3,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1,4,Therapeutic product effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
3,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
6,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
7,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
7,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
7,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
7,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
7,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
7,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
